Magnesium Amino Acid Chelate

South African indications: 

• Magnesium deficiency

Contraindications 

• Hypersensitivity to the active ingredient or any of its excipients 

Cautions 

• Pregnancy 
• Breastfeeding
• Renal impairment
• Hepatic impairment 
• Elderly 
• Diabetes mellitus 
• Excessive consumption

Forms avail. in SA and covered in this monograph: cap 

Magnesium deficiency

• Oral (cap): 125-900mg, dly

To be taken with food

Paed. forms avail. in SA and covered in this monograph: cap 

Magnesium deficiency

Younger than 9 years

• Not established for use 

Older than 9 years

• Oral (cap): 125-625mg, dly

To be taken with food

Pregnancy

• Caution; no information available

Breastfeeding

• Caution; no information available

Renal Impairment 

• Caution; no dose adjustment recommended

Hepatic Impairment 

• Caution; no information available

Elderly 

• Caution; no information available 

Porphyria Information

• Not yet classified (NC) 

Drugs in Sport

• Permitted - No warning 

Gastrointestinal Disorders 

• Diarrhoea

Antibiotics 

None routine 

Magnesium is essential for the activity of many enzyme systems and plays an important role with regard to neuro-chemical transmission and muscular excitability. 

Magnesium amino acid chelate is available in several formulations. Please note the list below gives examples of products which are available and is not necessarily comprehensive. The listing of a product does not constitute endorsement of the product by EMGuidance; likewise, failure to list a product does not imply that EMGuidance disapproves of the product. This information is put together on the basis of the National Government's Medicines Price Registry at the time of publication

Capsule 125mg

• Cipla Mag caps (Cipla)

Capsule 450mg

• Slow-mag (Merck)